NPI: 1831189638 · LAS VEGAS, NV 89144 · General Acute Care Hospital · NPI assigned 10/24/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 10/24/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 91,324 | $1.25M |
| 2019 | 244,331 | $4.90M |
| 2020 | 206,427 | $4.15M |
| 2021 | 223,780 | $5.02M |
| 2022 | 215,585 | $5.05M |
| 2023 | 229,782 | $5.39M |
| 2024 | 184,111 | $4.49M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 45,863 | 38,249 | $5.18M |
| G0378 | Hospital observation service, per hour | 21,566 | 15,530 | $2.51M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 26,491 | 24,003 | $2.39M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,194 | 7,832 | $2.13M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 34,651 | 30,085 | $1.87M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 32,024 | 7,083 | $859K |
| 70450 | Computed tomography, head or brain; without contrast material | 9,156 | 7,897 | $803K |
| 54161 | 2,140 | 2,025 | $794K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,971 | 2,534 | $715K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,944 | 3,329 | $647K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 33,892 | 26,445 | $536K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 23,278 | 4,444 | $489K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2,368 | 2,114 | $481K |
| 96375 | Therapeutic injection; each additional sequential IV push | 28,354 | 19,904 | $479K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 14,360 | 3,238 | $458K |
| 96361 | Intravenous infusion, hydration; each additional hour | 25,024 | 18,718 | $448K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9,892 | 9,134 | $356K |
| 59025 | Fetal non-stress test | 10,115 | 7,301 | $342K |
| 54300 | 401 | 381 | $331K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 13,481 | 11,127 | $297K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 9,079 | 7,811 | $287K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 582 | 493 | $225K |
| 80053 | Comprehensive metabolic panel | 48,971 | 37,763 | $221K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 70,447 | 49,737 | $212K |
| 96376 | 14,944 | 7,779 | $210K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 15,430 | 12,704 | $209K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6,946 | 5,574 | $198K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,771 | 1,443 | $191K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 14,601 | 9,393 | $188K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 967 | 719 | $182K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,186 | 1,905 | $181K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,831 | 2,435 | $170K |
| 71046 | Radiologic examination, chest; 2 views | 13,513 | 11,834 | $169K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,071 | 2,672 | $157K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 34,022 | 26,218 | $151K |
| 14040 | 821 | 781 | $148K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,023 | 1,873 | $136K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,564 | 1,935 | $131K |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 1,681 | 1,073 | $129K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 582 | 510 | $126K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,567 | 3,169 | $123K |
| 71045 | Radiologic examination, chest; single view | 20,496 | 16,781 | $123K |
| 36415 | Collection of venous blood by venipuncture | 89,447 | 57,484 | $120K |
| 76830 | Ultrasound, transvaginal | 1,710 | 1,474 | $119K |
| 76801 | 2,023 | 1,668 | $118K | |
| 84484 | 28,256 | 15,249 | $117K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,219 | 1,083 | $108K |
| 84702 | 18,706 | 15,674 | $105K | |
| 0450 | Emergency room services | 2,035 | 1,863 | $101K |
| 97161 | 3,846 | 3,035 | $97K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,117 | 987 | $92K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 539 | 466 | $89K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 6,156 | 5,834 | $87K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,379 | 1,482 | $87K |
| 70496 | 254 | 227 | $84K | |
| 72131 | 612 | 550 | $81K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 26,677 | 19,083 | $78K |
| 36430 | 3,343 | 2,008 | $72K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 6,207 | 1,332 | $70K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,346 | 1,129 | $68K |
| 93971 | 1,397 | 1,200 | $66K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,457 | 1,783 | $65K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,749 | 1,434 | $64K |
| 70498 | 286 | 257 | $64K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,513 | 3,070 | $64K |
| 97165 | 2,565 | 2,086 | $62K | |
| 54360 | 106 | 97 | $59K | |
| 93970 | 741 | 653 | $59K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,396 | 2,269 | $56K |
| J2785 | Injection, regadenoson, 0.1 mg | 490 | 408 | $56K |
| 83880 | 4,975 | 4,050 | $54K | |
| 83690 | 18,675 | 15,122 | $53K | |
| 97535 | Self-care/home management training, each 15 minutes | 4,449 | 2,362 | $52K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 21,185 | 12,638 | $47K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,432 | 3,839 | $47K |
| 74018 | 3,864 | 3,313 | $46K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 615 | 516 | $45K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 743 | 694 | $42K |
| 87040 | 8,694 | 5,507 | $42K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 12,494 | 10,535 | $41K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 482 | 349 | $40K |
| 86902 | 1,067 | 698 | $40K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,964 | 1,613 | $40K |
| 83605 | 9,493 | 7,184 | $38K | |
| 94644 | 1,245 | 1,133 | $35K | |
| 92526 | 803 | 301 | $33K | |
| 81001 | 24,763 | 20,812 | $33K | |
| 54304 | 38 | 38 | $33K | |
| 85730 | 17,781 | 13,874 | $32K | |
| 73564 | 1,423 | 1,287 | $29K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 31,634 | 22,659 | $26K |
| 83735 | 12,085 | 7,880 | $25K | |
| 81025 | 11,908 | 10,069 | $25K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,827 | 1,342 | $25K |
| 85610 | 21,761 | 16,914 | $25K | |
| 85379 | 5,320 | 4,507 | $22K | |
| 87641 | 3,881 | 2,986 | $22K | |
| 73630 | 1,336 | 1,212 | $22K | |
| 90715 | 420 | 383 | $22K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 363 | 195 | $21K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 5,908 | 4,169 | $21K |
| 73610 | 1,137 | 1,036 | $21K | |
| 84112 | 1,538 | 1,286 | $20K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 9,939 | 5,257 | $20K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 255 | 239 | $19K |
| 97602 | 1,080 | 484 | $18K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,393 | 887 | $18K |
| 58662 | 13 | 13 | $18K | |
| 84145 | 1,563 | 1,377 | $17K | |
| 87186 | 4,753 | 3,332 | $16K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,361 | 2,771 | $16K |
| 86923 | 2,912 | 1,877 | $16K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 10,840 | 9,764 | $15K |
| 70486 | 138 | 122 | $15K | |
| 73130 | 850 | 777 | $15K | |
| 86140 | 6,570 | 5,644 | $15K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,790 | 1,093 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 837 | 685 | $13K |
| 80076 | 4,020 | 3,283 | $13K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 821 | 671 | $13K |
| 70491 | 73 | 66 | $13K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 15,324 | 13,056 | $12K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 10,863 | 8,818 | $12K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,552 | 1,100 | $12K |
| 94664 | 1,382 | 1,022 | $12K | |
| 76775 | 433 | 369 | $12K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 3,250 | 2,727 | $12K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,902 | 1,050 | $11K |
| 73030 | 838 | 742 | $11K | |
| 85027 | 9,777 | 6,871 | $11K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 217 | 191 | $11K |
| 87507 | 272 | 257 | $11K | |
| 81003 | 12,429 | 10,413 | $10K | |
| 82962 | 15,196 | 6,428 | $10K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,496 | 1,159 | $10K |
| 86850 | 8,693 | 6,512 | $10K | |
| 93017 | 582 | 491 | $10K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 253 | 246 | $9K |
| 82731 | 430 | 356 | $9K | |
| 82803 | 1,483 | 1,140 | $9K | |
| 80061 | Lipid panel | 2,417 | 1,922 | $9K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 61 | 61 | $9K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 900 | 763 | $9K |
| 82550 | 3,512 | 2,840 | $9K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 3,382 | 1,919 | $9K |
| J2704 | Injection, propofol, 10 mg | 13,842 | 11,527 | $9K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 53 | 50 | $8K |
| 86901 | 10,052 | 7,667 | $8K | |
| 86900 | 9,734 | 7,405 | $8K | |
| 73110 | 398 | 354 | $8K | |
| 87077 | 1,934 | 1,436 | $8K | |
| 87631 | 2,440 | 2,050 | $8K | |
| J1644 | Injection, heparin sodium, per 1000 units | 5,378 | 2,297 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,660 | 2,140 | $7K |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 1,835 | 1,204 | $7K |
| 81002 | 5,656 | 4,355 | $7K | |
| C1769 | Guide wire | 2,161 | 1,563 | $6K |
| 82805 | 476 | 401 | $6K | |
| 12011 | 118 | 115 | $5K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,282 | 1,066 | $5K |
| 72100 | 377 | 312 | $5K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 8,509 | 5,852 | $5K |
| 73090 | 336 | 295 | $5K | |
| 80074 | 482 | 384 | $5K | |
| 96367 | 353 | 274 | $5K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,666 | 1,307 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 460 | 411 | $5K |
| 99152 | 796 | 611 | $5K | |
| 87070 | 1,763 | 1,385 | $4K | |
| 73590 | 306 | 295 | $4K | |
| 82728 | 1,393 | 965 | $4K | |
| 74022 | 194 | 171 | $4K | |
| 84439 | 1,440 | 1,216 | $4K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 5,993 | 4,709 | $4K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 6,353 | 5,031 | $4K |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,415 | 691 | $4K |
| 73080 | 231 | 203 | $4K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 36 | 24 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 12,477 | 9,996 | $4K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 216 | 110 | $4K |
| 93880 | 47 | 39 | $3K | |
| 58571 | 33 | 29 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,659 | 1,491 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | 7,132 | 5,488 | $3K |
| 84100 | 2,207 | 1,410 | $3K | |
| C9113 | Injection, pantoprazole sodium, per vial | 1,887 | 1,074 | $3K |
| 85046 | 2,039 | 1,405 | $3K | |
| 86644 | 489 | 287 | $3K | |
| 87205 | 2,221 | 1,594 | $3K | |
| 82570 | 1,057 | 862 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | 4,846 | 3,500 | $3K |
| 84550 | 1,239 | 998 | $3K | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 37 | 33 | $3K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 16 | 16 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,418 | 970 | $2K |
| 87210 | 1,117 | 957 | $2K | |
| 76818 | 30 | 28 | $2K | |
| 83615 | 811 | 672 | $2K | |
| 76870 | 66 | 61 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 913 | 720 | $2K |
| 80069 | 993 | 527 | $2K | |
| 84132 | 1,547 | 1,156 | $2K | |
| 85652 | 1,630 | 1,378 | $2K | |
| 0250 | 63 | 24 | $2K | |
| 84156 | 1,007 | 825 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 94 | 87 | $2K |
| 87276 | 469 | 431 | $2K | |
| 87486 | 114 | 95 | $2K | |
| 87581 | 114 | 95 | $2K | |
| 87275 | 470 | 432 | $2K | |
| J3490 | Unclassified drugs | 133 | 99 | $2K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 12 | 12 | $1K |
| 82330 | 267 | 224 | $1K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 14 | 14 | $1K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 799 | 605 | $1K |
| C1781 | Mesh (implantable) | 44 | 26 | $1K |
| 86780 | 279 | 237 | $1K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,881 | 6,268 | $1K |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 21 | 13 | $1K |
| 12001 | 30 | 30 | $1K | |
| 73502 | 57 | 49 | $1K | |
| J1630 | Injection, haloperidol, up to 5 mg | 711 | 477 | $1K |
| 74230 | 12 | 12 | $1K | |
| 29125 | 28 | 26 | $909.70 | |
| 82140 | 213 | 158 | $908.79 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 679 | 601 | $837.70 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 132 | 109 | $825.85 |
| 87420 | 170 | 155 | $768.13 | |
| 82565 | 558 | 402 | $754.99 | |
| J1940 | Injection, furosemide, up to 20 mg | 235 | 129 | $739.54 |
| J0456 | Injection, azithromycin, 500 mg | 311 | 217 | $711.01 |
| 85660 | 732 | 268 | $683.70 | |
| 87081 | 470 | 356 | $635.97 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 417 | 362 | $626.90 |
| 82010 | 224 | 178 | $619.87 | |
| G0008 | Administration of influenza virus vaccine | 109 | 91 | $609.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 489 | 333 | $594.61 |
| 85018 | 869 | 655 | $580.68 | |
| J1790 | Injection, droperidol, up to 5 mg | 141 | 127 | $564.49 |
| 85014 | 806 | 609 | $554.15 | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 15 | 13 | $533.81 |
| 88307 | 74 | 40 | $532.14 | |
| 83021 | 92 | 62 | $507.71 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 86 | 72 | $479.42 |
| 87430 | 145 | 135 | $474.33 | |
| 83550 | 250 | 197 | $464.72 | |
| 90686 | 108 | 90 | $451.08 | |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 201 | 132 | $430.77 |
| 72040 | 40 | 27 | $420.21 | |
| 92610 | 12 | 12 | $388.10 | |
| 83540 | 247 | 196 | $368.43 | |
| 84295 | 246 | 209 | $359.28 | |
| 83020 | 225 | 124 | $357.16 | |
| 88312 | 261 | 189 | $289.54 | |
| 97116 | 76 | 34 | $275.66 | |
| 82947 | 215 | 187 | $269.24 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 84 | 43 | $258.20 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 114 | 79 | $212.96 |
| J3360 | Injection, diazepam, up to 5 mg | 18 | 17 | $206.44 |
| 72072 | 24 | 14 | $201.18 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 178 | 125 | $187.66 |
| 71101 | 12 | 12 | $182.97 | |
| 94645 | 14 | 12 | $156.63 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 26 | 15 | $88.65 |
| J1953 | Injection, levetiracetam, 10 mg | 12 | 12 | $82.11 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 139 | 117 | $81.40 |
| 82248 | 33 | 26 | $78.66 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 990 | 841 | $70.63 |
| 85007 | 110 | 67 | $65.80 | |
| J1836 | Injection, metronidazole, 10 mg | 97 | 60 | $65.77 |
| 99153 | Mod sedat endo service >5yrs | 114 | 94 | $53.76 |
| 82607 | 20 | 14 | $53.47 | |
| A9270 | Non-covered item or service | 14,640 | 2,326 | $51.20 |
| J8540 | Dexamethasone, oral, 0.25 mg | 42 | 40 | $43.92 |
| J0736 | Injection, clindamycin phosphate, 300 mg | 35 | 25 | $37.53 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 67 | 66 | $17.75 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 16 | 12 | $14.96 |
| 84520 | 24 | 16 | $13.55 | |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 15 | 13 | $4.97 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 179 | 160 | $4.20 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 123 | 96 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 132 | 96 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 191 | 149 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 902 | 669 | $0.00 |
| C1729 | Catheter, drainage | 218 | 168 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 303 | 227 | $0.00 |
| 0353U | 202 | 186 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 322 | 226 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 113 | 94 | $0.00 |
| G8989 | Self care functional limitation, discharge status, at discharge from therapy or to end reporting | 52 | 39 | $0.00 |
| 97537 | 76 | 55 | $0.00 |